Distinguishing Pathovars from Nonpathovars: Escherichia coli.
Riley LW.
Microbiol Spectr. 2020 Dec;8(4):10.1128/microbiolspec.ame-0014-2020. doi: 10.1128/microbiolspec.AME-0014-2020.
Escherichia coli bacteraemia.
OWEN T, SPAULDING WB.
Can Med Assoc J. 1956 Dec 15;75(12):1020-4.
Escherichia coli--an overview.
Cooke EM.
J Hyg (Lond). 1985 Dec;95(3):523-30. doi: 10.1017/s022217240006065x.
Proteomics of septicemic Escherichia coli.
Otto A, Biran D, Sura T, Becher D, Ron EZ.
Proteomics Clin Appl. 2016 Oct;10(9-10):1020-1024. doi: 10.1002/prca.201600049.
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Qureshi ZA, Doi Y.
Expert Rev Anti Infect Ther. 2014 May;12(5):597-609. doi: 10.1586/14787210.2014.899901. Epub 2014 Apr 2.
What makes Escherichia coli pathogenic?
Siitonen A.
Ann Med. 1994 Aug;26(4):229-31. doi: 10.3109/07853899409147895.
Clonality and virulence traits of Escherichia coli associated with haemorrhagic septicaemia in turkeys.
Olsen RH, Chadfield MS, Christensen JP, Scheutz F, Christensen H, Bisgaard M.
Avian Pathol. 2011 Dec;40(6):587-95. doi: 10.1080/03079457.2011.618942.
Neonatal septicaemia caused by diverse clones of Klebsiella pneumoniae & Escherichia coli harbouring blaCTX-M-15.
Roy S, Gaind R, Chellani H, Mohanty S, Datta S, Singh AK, Basu S.
Indian J Med Res. 2013 Apr;137(4):791-9.
Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S, Datta S, Viswanathan R, Singh AK, Basu S.
J Antimicrob Chemother. 2013 May;68(5):1036-42. doi: 10.1093/jac/dks535. Epub 2013 Jan 18.
Lactobacillus rhamnosus modulates murine neonatal gut microbiota and inflammation caused by pathogenic Escherichia coli.
Xuan H, Umar S, Zhong C, Yu W, Ahmed I, Wheatley JL, Sampath V, Chavez-Bueno S.
BMC Microbiol. 2024 Nov 6;24(1):452. doi: 10.1186/s12866-024-03598-6.
